-
EP4304613
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4304613
| EP4304613 - BIOMARKERS FOR IDENTIFYING AND TREATING CANCER PATIENTS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.12.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 16.09.2022 | Most recent event Tooltip | 17.05.2024 | Change: Validation states | published on 19.06.2024 [2024/25] | 17.05.2024 | Change - extension states | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states Mayo Foundation for Medical Education and Research 200 First Street S.W. Rochester, Minnesota 55905 / US | [2024/03] | Inventor(s) | 01 /
BORNSCHLEGL, Svetlana Rochester, Minnesota 55902 / US | 02 /
DIETZ, Allan B. Chatfield, Minnesota 55923 / US | 03 /
GUSTAFSON, Michael P. Rochester, Minnesota 55901 / US | [2024/03] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [2024/03] | Application number, filing date | 22767865.3 | 09.03.2022 | [2024/03] | WO2022US19487 | Priority number, date | US202163158740P | 09.03.2021 Original published format: US 202163158740 P | [2024/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022192353 | Date: | 15.09.2022 | Language: | EN | [2022/37] | Type: | A1 Application with search report | No.: | EP4304613 | Date: | 17.01.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.09.2022 takes the place of the publication of the European patent application. | [2024/03] | Search report(s) | International search report - published on: | US | 15.09.2022 | Classification | IPC: | A61K35/17, A61P35/00, C12Q1/6886 | [2024/03] | CPC: |
A61P35/00 (EP,US);
G01N33/57484 (EP,US);
C07K16/2818 (EP,US);
C07K16/2827 (EP);
A61K2039/505 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/03] | Title | German: | BIOMARKER ZUR IDENTIFIZIERUNG UND BEHANDLUNG VON KREBSPATIENTEN | [2024/03] | English: | BIOMARKERS FOR IDENTIFYING AND TREATING CANCER PATIENTS | [2024/03] | French: | BIOMARQUEURS POUR L'IDENTIFICATION ET LE TRAITEMENT DE PATIENTS ATTEINTS D'UN CANCER | [2024/03] | Entry into regional phase | 28.09.2023 | National basic fee paid | 28.09.2023 | Search fee paid | 28.09.2023 | Designation fee(s) paid | 28.09.2023 | Examination fee paid | Examination procedure | 28.09.2023 | Examination requested [2024/03] | 12.04.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 26.02.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2015117164 (SLOAN KETTERING INST CANCER [US]) [X] 1-3, 5-7, 17-19, 25-27, 29 -31 * abstract, pg 6, In 15-19, pg 7, In 1-2, pg 7, In 5-9, pg 7, In 14-17, pg 8, In 9, pg 8, In 10-16, pg 10, In 10-16, pg 12, 14-19, pg 38, In 7-15 *; | [A]WO2020141199 (INST NAT SANTE RECH MED [FR], et al) [A] 1* abstract * |